Expired activity
Please go to the PowerPak homepage and select a course.

Improving Outcomes in Ovarian Cancer: Focus on PARP Inhibitors and Pharmacist Implications (Recorded Podcast)

Point-of-Care Reference Tool »


Amy L. Indorf, PharmD, BCOP
Clinical Oncology Pharmacist
UW Medicine
Seattle Cancer Alliance
Seattle, WA

Upon completion of this activity, participants should be better able to:

  1. Identify the role of PARP inhibitors in the treatment of ovarian cancer
  2. Describe the differing safety profiles of available PARP inhibitors and implications on individualized treatment strategies

Back to Top